International trade · 22/12/2025

USITC Investigates AbbVie, ImmunoGen for Alleged Trade Secret Misappropriation

The US International Trade Commission (USITC) has launched an investigation into AbbVie, ImmunoGen, and ImmunoGen Switzerland, alleging they misappropriated trade secrets related to antibody drug conjugates and components, which could harm the US industry.